Citadel Advisors LLC 13D/13G Filings for Dianthus Therapeutics, Inc. (DNTH)

Citadel Advisors LLC 13D and 13G filings for Dianthus Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-14
4:58 pm
Purchase
2023-12-3113GDianthus Therapeutics, Inc.
DNTH
Citadel Advisors LLC2,880
0.000%
2,880increase
(New Position)
Filing